Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
Nurix Therapeutics (NRIX) Financial Statements
378 Followers
Nurix Therapeutics Financial Overview
| May 24 | Feb 24 | Nov 23 | Aug 23 | May 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 12.09M | $ 16.59M | $ 15.16M | $ 18.47M | $ 30.68M |
| Gross Profit | $ 12.09M | $ 16.59M | $ 15.16M | $ 18.47M | $ 30.68M |
| EBIT | $ -44.46M | $ -45.22M | $ -41.96M | $ -36.98M | $ -24.28M |
| EBITDA | $ -38.44M | $ -41.33M | $ -40.20M | $ -35.24M | $ -21.93M |
| Net Income Common Stockholders | $ -44.55M | $ -41.52M | $ -41.96M | $ -36.98M | $ -24.28M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 443.14M | $ 49.81M | $ 54.63M | $ 258.85M | $ 281.18M |
| Total Assets | $ 511.03M | $ 312.67M | $ 355.60M | $ 308.19M | $ 350.62M |
| Total Debt | $ 28.82M | $ 29.16M | $ 30.61M | $ 8.00M | $ 9.34M |
| Net Debt | $ -414.32M | $ -20.66M | $ -24.01M | $ -250.85M | $ -271.84M |
| Total Liabilities | $ 140.34M | $ 143.93M | $ 155.10M | $ 74.38M | $ 90.70M |
| Stockholders Equity | $ 370.66M | $ 168.75M | $ 200.49M | $ 233.86M | $ 259.88M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -41.64M | $ -44.84M | $ 24.10M | $ -43.59M | $ -19.55M |
| Operating Cash Flow | $ -39.70M | $ -41.95M | $ 26.69M | $ -41.13M | $ -18.47M |
| Investing Cash Flow | $ -131.07M | $ 35.51M | $ -14.37M | $ 22.77M | $ 43.83M |
| Financing Cash Flow | $ 237.75M | $ 1.62M | $ 7.00K | $ 1.70M | $ 25.00K |